Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on symptoms in irritable bowel syndrome: randomized double-blind controlled trial
TCTR20250916001Phase 3Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in irritable bowel syndrome (IBS) (2 arms), sponsored by Chulalongkorn University. Started Jun 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on TCTR20250916001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250916001.